Abstract
B cell-activating factor (BAFF) production is increased in septic patients. However, the specific role of BAFF in sepsis remains unknown. This study was designed to investigate the expression and function of BAFF in an experimental endotoxemia model and to identify the potential mechanisms. We established an endotoxemia mouse (6–8 weeks, 20–22 g) model by administering 30 mg/kg lipopolysaccharide (LPS). BAFF levels in the circulating system and organ tissues were measured 4 and 8 h after LPS injection. Survival rates in the endotoxemia mice were monitored for 72 h after BAFF blockade. The effects of BAFF blockade on systemic and local inflammation, organ injuries, and intestinal barrier function were also evaluated 4 h after LPS treatment. BAFF production was systemically and locally elevated after LPS challenge. BAFF blockade improved the survival rate, systemic inflammation, and multi-organ injuries. Moreover, BAFF blockade attenuated both intestinal inflammation and impaired intestinal permeability. BAFF blockade upregulated ZO-1 and occludin protein levels via the NF-κB/MLCK/MLC signaling pathway. These results suggested that BAFF blockade protects against lethal endotoxemia at least partially by alleviating inflammation, multi-organ injuries, and improving intestinal barrier function and provides a novel focus for further research on sepsis and experimental evidence for clinical therapy.
Highlights
Sepsis is a life-threatening multi-organ dysfunction that results from dysregulated host immune response to microorganism infection [1]
Our results show that serum interleukin 1b (IL-1b), interleukin 6 (IL-6), and tumor necrosis factor (TNF)-a levels were significantly increased after LPS challenge, while serum interleukin 10 (IL-10) levels decreased (Figure 2C)
We found that IL-1b, IL-6, tumor necrosis factor a (TNF-a), and IL-10 expression was increased in the LPS group, and that BAFF blockade significantly lowered their expression
Summary
Sepsis is a life-threatening multi-organ dysfunction that results from dysregulated host immune response to microorganism infection [1]. Despite advances in medical treatment, the mortality rate of patients with sepsis remains alarmingly high [2]. Systemic and local immunological dissonance triggered by microbial infection results in an uncontrolled inflammatory response and subsequent multi-organ dysfunction [3]. The intestinal tract is an important effector organ for sepsis and is considered the motor of critical illness [4]. Intestinal barrier impairment plays a vital role in the development of systemic sepsis [4]. Intestinal hyperpermeability is associated with alterations in tight junctions (TJ) between intestinal
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
